Skip to content
Oncology Research Hub

South Carolina

Cancer clinical trials in South Carolina

176 cancer studies are recruiting participants at sites in 29 cities across South Carolina as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 343-1186
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every South Carolina city with a recruiting study

By research area: Prostate Cancer (49), Lung Cancer (44), Breast Cancer (40), Lymphoma (30), Pancreatic Cancer (7), Melanoma (6).

Charleston (91), Greenville (67), Myrtle Beach (34), Greer (29), Boiling Springs (21), Seneca (21), Bluffton (19), Easley (19), Spartanburg (19), Hilton Head Island (14), Columbia (13), Gaffney (11), Rock Hill (11), Union (11), Georgetown (10), West Columbia (10), Florence (8), Anderson (7), Greenwood (4), Lancaster (4), Murrells Inlet (4), Beaufort (3), Clinton (2), North Charleston (2), Orangeburg (2), Hardeeville (1), Mt. Pleasant (1), Okatie (1), Summerville (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Breast cancer: recently updated in South Carolina

Basic details from each study's public record (the 12 most recently updated of 176). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Greenville
    Registry record
    NCT06686394 · updated
  2. S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    SWOG Cancer Research Network
    Recruiting in
    Greenville
    Registry record
    NCT03418961 · updated

Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in South Carolina on ClinicalTrials.gov.

Lung cancer: recently updated in South Carolina

  1. LiveWell: An Adapted Dialectical Behavioral Therapy Skills Training Protocol for Patients Living With Metastatic Lung Cancer

    • No phase
    • Ages 18 and older
    • All sexes
    Sponsor
    Medical University of South Carolina
    Recruiting in
    Charleston
    Registry record
    NCT07177846 · updated
  2. A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pfizer
    Recruiting in
    Myrtle Beach
    Registry record
    NCT03460977 · updated
  3. A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

    • Phase 3
    • Ages 18 to 100
    • All sexes
    Sponsor
    Amgen
    Recruiting in
    Lancaster
    Registry record
    NCT05920356 · updated

Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in South Carolina on ClinicalTrials.gov.

Prostate cancer: recently updated in South Carolina

  1. High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

    • Phase 2
    • Ages 18 and older
    • Male participants
    Sponsor
    VA Office of Research and Development
    Recruiting in
    Charleston
    Registry record
    NCT05011383 · updated
  2. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

    • Phase 3
    • Ages 18 and older
    • Male participants
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Charleston
    Registry record
    NCT04423211 · updated
  3. TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

    • Phase 1/2
    • Ages 18 and older
    • Male participants
    Sponsor
    Novartis Pharmaceuticals
    Recruiting in
    Charleston · Myrtle Beach
    Registry record
    NCT07190300 · updated

Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in South Carolina on ClinicalTrials.gov.

Melanoma: recently updated in South Carolina

  1. Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

    • Phase 3
    • Ages 75 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Charleston
    Registry record
    NCT07068074 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in South Carolina on ClinicalTrials.gov.

Ask about studies in South Carolina

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Oncology Research Hub does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-1186

or send a short form

How should we reach you?

Call